Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

NZ dairy giant Fonterra seals partnership deal with U.S. biotech firm VitaKey

Published 11/03/2021, 09:05 PM
Updated 11/03/2021, 09:11 PM
© Reuters. FILE PHOTO: The Fonterra logo is seen near the Fonterra Te Rapa plant near Hamilton, New Zealand, August 6, 2013.   REUTERS/Nigel Marple/File Photo

© Reuters. FILE PHOTO: The Fonterra logo is seen near the Fonterra Te Rapa plant near Hamilton, New Zealand, August 6, 2013. REUTERS/Nigel Marple/File Photo

(Reuters) - New Zealand dairy giant Fonterra said on Thursday it had struck a partnership deal with U.S.-based biotech firm VitaKey to look at ways to prolong freshness and nutrients of products using probiotic strains.

In a statement, Fonterra said it was looking to design dairy products that include time-controlled release of specific dairy nutrients, starting with probiotics that would keep it fresher for longer and allow nutrients to be more active. It didn't disclose financial terms of the partnership.

The cooperation deal comes as global supply chain disruptions highlight the need to bolster the storage duration of products while retaining their nutrition. The coronavirus pandemic has also increased healthy diet concerns as people around the world adapt to lifestyles that often include extended period working or staying at home.

"We can really drive our 'Active Living' business by appealing to the growing health and wellness consumer segment that desire the maximum functional benefits from food," said Judith Swales, chief executive officer for Fonterra's Asia-Pacific region.

© Reuters. FILE PHOTO: The Fonterra logo is seen near the Fonterra Te Rapa plant near Hamilton, New Zealand, August 6, 2013.   REUTERS/Nigel Marple/File Photo

"Because the nutrients are encapsulated and highly targeted, it also means we can use less milk in our production, making our milk go further while reducing food waste," Swales said.

VitaKey's nutrients platform is based on technology licensed from the Massachusetts Institute of Technology and developed at the Langer Lab.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.